Ignite Creation Date:
2024-05-06 @ 6:58 PM
Last Modification Date:
2024-10-26 @ 2:57 PM
Study NCT ID:
NCT05844163
Status:
RECRUITING
Last Update Posted:
2023-05-06
First Post:
2023-04-25
Brief Title:
Treatment Strategies for Unruptured Intracranial Aneurysms in the Chinese Population China Treatment Trial for Unruptured Intracranial Aneurysm ChTUIA
Sponsor:
Beijing Tiantan Hospital
Organization:
Beijing Tiantan Hospital
Study Overview
Official Title:
Treatment Strategies for Unruptured Intracranial Aneurysms in the Chinese Population China Treatment Trial for Unruptured Intracranial Aneurysm ChTUIA
Status:
RECRUITING
Status Verified Date:
2023-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ChTUIA
Brief Summary:
The goal of this prospective observational cohort study is to learn about treatment strategies for unruptured intracranial aneurysms in the Chinese population The main questions it aims to answer are
To establish a cohort of patients with intracranial unruptured aneurysm and explore the optimal clinical treatment strategy
To establish clinical management path for patients with unruptured intracranial aneurysm
According to the treatment of all patients with unruptured intracranial aneurysm they were divided into the following groups 1 Conservative treatment group 2 Intracranial aneurysm clipping group 3 Coil embolization or stent-assisted coil embolization group 4 Flow diversion group
To establish a cohort of patients with intracranial unruptured aneurysm and explore the optimal clinical treatment strategy
To establish clinical management path for patients with unruptured intracranial aneurysm
According to the treatment of all patients with unruptured intracranial aneurysm they were divided into the following groups 1 Conservative treatment group 2 Intracranial aneurysm clipping group 3 Coil embolization or stent-assisted coil embolization group 4 Flow diversion group
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None